총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Ultragenyx Pharmaceutical Inc. (RARE), 포함 18 건 매수 및 32 건 매도. 내부자 매수 총액은 $7.36M 내부자 매도 총액은 $8.65M.
최근 활동이 있는 주요 내부자에는 Horn Howard, Parschauer Karah Herdman, Kakkis Emil D. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — RARE
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2026-04-01 |
Horn Howard |
Chief Financial Officer |
정보 매도 |
4,683 |
$20.97 |
$98.2K |
80,351 |
| 2026-03-10 |
Parschauer Karah Herdman |
EVP and Chief Legal Officer |
정보 매도 |
3,508 |
$22.67 |
$79.53K |
66,820 |
| 2026-03-06 |
Parschauer Karah Herdman |
EVP and Chief Legal Officer |
정보 매도 |
6,018 |
$21.40 |
$128.79K |
70,328 |
| 2026-03-03 |
Horn Howard |
Chief Financial Officer |
정보 매도 |
1,635 |
$22.40 |
$36.62K |
85,034 |
| 2026-03-02 |
Kakkis Emil D |
President & CEO |
정보 매도 |
54,404 |
$22.80 |
$1.24M |
658,994 |
| 2026-03-02 |
Huizenga Theodore Alan |
SVP, Chief Accounting Officer |
정보 매도 |
1,632 |
$22.80 |
$37.21K |
48,670 |
| 2026-03-02 |
Huang Dennis Karl |
See Remarks |
RSU 원천징수 |
999 |
$23.39 |
$23.37K |
124,729 |
| 2026-03-02 |
Pinion John Richard |
See Remarks |
정보 매도 |
10,029 |
$22.80 |
$228.66K |
110,026 |
| 2026-03-02 |
Crombez Eric |
EVP and Chief Medical Officer |
정보 매도 |
7,029 |
$22.80 |
$160.26K |
76,301 |
| 2026-03-02 |
Parschauer Karah Herdman |
EVP and Chief Legal Officer |
정보 매도 |
8,135 |
$22.80 |
$185.48K |
76,346 |
| 2026-03-02 |
Harris Erik |
EVP & Chief Commercial Officer |
정보 매도 |
10,539 |
$22.80 |
$240.29K |
89,515 |
| 2026-03-02 |
Horn Howard |
Chief Financial Officer |
정보 매도 |
3,119 |
$22.54 |
$70.3K |
86,669 |
| 2026-03-01 |
Kakkis Emil D |
President & CEO |
RSU 부여 |
71,177 |
- |
- |
712,908 |
| 2026-03-01 |
Huang Dennis Karl |
See Remarks |
RSU 부여 |
11,137 |
- |
- |
125,728 |
| 2026-03-01 |
Pinion John Richard |
See Remarks |
RSU 부여 |
11,137 |
- |
- |
119,565 |
| 2026-03-01 |
Crombez Eric |
EVP and Chief Medical Officer |
RSU 부여 |
11,643 |
- |
- |
83,173 |
| 2026-03-01 |
Parschauer Karah Herdman |
EVP and Chief Legal Officer |
RSU 부여 |
11,137 |
- |
- |
84,408 |
| 2026-03-01 |
Harris Erik |
EVP & Chief Commercial Officer |
RSU 부여 |
11,643 |
- |
- |
99,498 |
| 2026-03-01 |
Horn Howard |
Chief Financial Officer |
RSU 부여 |
6,143 |
- |
- |
95,078 |
| 2026-02-02 |
Horn Howard |
Chief Financial Officer |
정보 매도 |
3,061 |
$23.56 |
$72.12K |
88,935 |
| 2026-01-02 |
Horn Howard |
Chief Financial Officer |
정보 매도 |
3,150 |
$22.84 |
$71.95K |
91,996 |
| 2025-12-29 |
Huizenga Theodore Alan |
SVP, Chief Accounting Officer |
정보 매도 |
85 |
$34.38 |
$2.92K |
50,450 |
| 2025-12-10 |
Horn Howard |
Chief Financial Officer |
정보 매도 |
3,081 |
$36.38 |
$112.09K |
95,146 |
| 2025-10-13 |
Horn Howard |
Chief Financial Officer |
정보 매도 |
7,942 |
$31.51 |
$250.25K |
98,227 |
| 2025-09-18 |
Huizenga Theodore Alan |
SVP, Chief Accounting Officer |
정보 매도 |
64 |
$29.17 |
$1.87K |
50,242 |
| 2025-09-12 |
Parschauer Karah Herdman |
EVP and Chief Legal Officer |
정보 매도 |
2,450 |
$31.17 |
$76.37K |
73,271 |
| 2025-09-05 |
Huizenga Theodore Alan |
SVP, Chief Accounting Officer |
정보 매도 |
84 |
$31.39 |
$2.64K |
50,306 |
| 2025-06-20 |
Sanders Corazon (corsee) D. |
Director |
정보 매도 |
2,405 |
$37.39 |
$89.92K |
15,344 |
| 2025-05-15 |
Welch Daniel G |
Director |
RSU 부여 |
10,787 |
$34.84 |
$375.82K |
10,787 |
| 2025-05-15 |
Dunsire Deborah |
Director |
RSU 부여 |
10,787 |
$34.84 |
$375.82K |
10,787 |
| 2025-05-15 |
Narachi Michael |
Director |
RSU 부여 |
10,787 |
$34.84 |
$375.82K |
10,787 |
| 2025-05-15 |
Fust Matthew K |
Director |
RSU 부여 |
10,787 |
$34.84 |
$375.82K |
10,787 |
| 2025-05-15 |
Suliman Shehnaaz |
Director |
RSU 부여 |
10,787 |
$34.84 |
$375.82K |
10,787 |
| 2025-05-15 |
Sanders Corazon (corsee) D. |
Director |
RSU 부여 |
10,787 |
$34.84 |
$375.82K |
10,787 |
| 2025-05-15 |
Ray Amrit |
Director |
RSU 부여 |
10,787 |
$34.84 |
$375.82K |
10,787 |
| 2025-05-05 |
Crombez Eric |
EVP and Chief Medical Officer |
정보 매도 |
520 |
$39.24 |
$20.4K |
71,530 |
| 2025-04-21 |
Crombez Eric |
EVP and Chief Medical Officer |
정보 매도 |
242 |
$35.11 |
$8.5K |
71,680 |
| 2025-03-06 |
Horn Howard |
Chief Financial Officer |
정보 매도 |
1,785 |
$40.40 |
$72.11K |
106,169 |
| 2025-03-03 |
Kakkis Emil D |
President & CEO |
정보 매도 |
73,434 |
$42.10 |
$3.09M |
641,731 |
| 2025-03-03 |
Kassberg Thomas Richard |
Cbo & EVP |
RSU 원천징수 |
508 |
$42.92 |
$21.8K |
264,730 |
| 2025-03-03 |
Huizenga Theodore Alan |
SVP, Chief Accounting Officer |
RSU 원천징수 |
141 |
$42.92 |
$6.05K |
50,124 |
| 2025-03-03 |
Huang Dennis Karl |
See Remarks |
RSU 원천징수 |
1,348 |
$42.92 |
$57.86K |
114,591 |
| 2025-03-03 |
Pinion John Richard |
See Remarks |
정보 매도 |
14,439 |
$42.10 |
$607.88K |
107,766 |
| 2025-03-03 |
Crombez Eric |
EVP and Chief Medical Officer |
정보 매도 |
8,945 |
$42.10 |
$376.58K |
71,922 |
| 2025-03-03 |
Parschauer Karah Herdman |
EVP and Chief Legal Officer |
정보 매도 |
12,846 |
$42.10 |
$540.82K |
75,287 |
| 2025-03-03 |
Harris Erik |
EVP & Chief Commercial Officer |
정보 매도 |
15,103 |
$42.10 |
$635.84K |
87,855 |
| 2025-03-01 |
Parschauer Karah Herdman |
EVP and Chief Legal Officer |
RSU 부여 |
26,074 |
$42.92 |
$1.12M |
26,074 |
| 2025-03-01 |
Kakkis Emil D |
President & CEO |
RSU 부여 |
78,448 |
$42.92 |
$3.37M |
78,448 |
| 2025-03-01 |
Kassberg Thomas Richard |
Cbo & EVP |
RSU 부여 |
18,443 |
- |
- |
271,266 |
| 2025-03-01 |
Huizenga Theodore Alan |
SVP, Chief Accounting Officer |
RSU 부여 |
5,632 |
$42.92 |
$241.73K |
5,632 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료
